Enter your terms above and click the 'Search' button.

Showing articles 0 to 12 of 12 Filter Applied: multiple sclerosis,treatment of (Click to remove) Drug Reaction with Eosinophilia and Systemic Symptoms after Daclizamub Therapy Neurol 91:e359-e363, Rauer,S.,et al, 2018 Multiple Sclerosis Rebound Following Herpes Zoster Infection and Suspension of Fingolimod Neurol 79:2006-2007,1942, Gross, C.M.,et al, 2012 Clinical and MRI Outcome after Autologous Hematoipoietic Stem Cell Transplantation in MS Neurol 62:282-284,168, Saiz,A.,et al, 2004 Multiple Sclerosis NEJM 378:169-180, Reich, D.S.,et al, 2018 Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis NEJM 362:402-415, 456, Cohen,J.A.,et al, 2010 B-Cell Depletion with Rituximab in Relapsing-Remitting Multiple Sclerosis NEJM 358:676-688, Hauser,S.L.,et al, 2008 Multiple Sclerosis Lancet 372:1502-1517, Compston,A. &Coles,A., 2008 Evidence for Widespread Axonal Damage at the Earliest Clinical Stage of Multiple Sclerosis Brain 126:433-437, Filippi,M.,et al, 2003 High- and Low-Risk Profiles for the Development of Multiple Sclerosis Within 10 Years After Optic Neuritis Arch Ophthalmol 121:944-949, Optic Neuritis Study Group, 2003 Multiple Sclerosis Lancet 359:1221-1231, Compston,A. &Coles,A., 2002 Multiple Sclerosis NEJM 343:938-952, Noseworthy,J.H. et al, 2000 Multiple Sclerosis, (Second of Two Parts) NEJM 307:1246-1251, McFarlin,D.E.,et al, 1982 Showing articles 0 to 12 of 12